Articles from The Collaborative Trajectory Analysis Project (cTAP)

The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA) in patients with Duchenne muscular dystrophy (DMD). According to research published May 26, 2026, in Neurology®, the medical journal of the American Academy of Neurology, this simple, easy-to-use score, based on two common functional assessments, rise from floor, and 10-meter walk/run, provides a more refined risk stratification nods and can better inform clinical decision-making and research than previously reported models. Its publication represents the most recent addition to cTAP’s suite of open access prognostic models and insights developed to support improved trial design and disease state understanding in DMD. “This new prognostic score represents a significant advancement in managing Duchenne muscular dystrophy,” said Craig McDonald, MD, Professor, University of California at Davis Medical Center. "By providing clinicians with a simple yet powerful tool to predict time to loss of ambulation, we can better counsel patients and families, optimize trial design, and ultimately improve the quality of care for individuals living with Duchenne.”